Skip to main content

CDC Advisers Say High-Risk Men Should Still Get Mpox Vaccine

Medically reviewed by Drugs.com.

By Physician’s Briefing Staff HealthDay Reporter

THURSDAY, Oct. 26, 2023 -- High-risk men should still get their mpox vaccinations even after the ongoing outbreak ends, advisers to the U.S. Centers for Disease Control and Prevention recommended Wednesday.

That vulnerable group includes men who have sex with men; people who have more than one sexual partner; those who have recently had a sexually transmitted disease; and people who are at higher risk for infections through sexual contact for other reasons.

CDC Director Mandy Cohen will still need to sign off on that recommendation, which came during a meeting of the CDC Advisory Committee on Immunization Practices.

The virus, formerly called monkeypox, is in the same family of viruses as smallpox and is endemic in parts of Africa. About 800 cases of mpox have been reported in the United States in 2023 compared with 30,000 last year, according to the CDC. In 2022, cases spread widely among men who have sex with men in Europe and the United States.

Now, the daily average of new cases is one to four per day. Two deaths were reported in September, while a total of 54 have died in the U.S. outbreaks, the Associated Press reported. Many suffered painful lesions for weeks. In San Francisco, where there were more than 800 cases last year, the numbers are now much lower although they vary. In August, there were seven, in September there were 20, and this month has had at least 10 known cases, the AP reported.

To stem the spread of mpox, the two-dose Jynneos vaccine has been distributed to more than 500,000 people in the United States. Still, about 2 million people are eligible for the shot, according to the CDC.

Associated Press Article

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

Read this next

COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes

TUESDAY, June 25, 2024 -- mRNA COVID-19 vaccination during pregnancy is not associated with an increased risk of adverse pregnancy outcomes, according to a study published in the...

FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine

FRIDAY, June 21, 2024 -- The U.S. Food and Drug Administration has approved the Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal...

No Evidence That Live Vaccines Are Unsafe for Patients on Dupilumab

FRIDAY, June 14, 2024 -- There is no evidence to suggest that administration of live vaccines to patients receiving dupilumab is unsafe, and vaccine efficacy is not affected by...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.